Combinostics is a software advanced tools for data-driven diagnostics, giving the physician a holistic view of all patient data.

Combinostics provides cloud-based tools for extracting biomarkers from images, lab data and cognitive tests and integrating and contrasting all data with data from previously diagnosed patients.

Combinostics was founded in 2014 and is based in Tampere, Western Finland, Finland.


Combinostics' cNeuro, is a cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders. cNeuro® has two product modules, cMRI and cDSI.


Combinostics' cNeuro gives healthcare professionals a comprehensive view of patient data which helps them to make an early diagnosis of neurodegenerative diseases.


Combinostics is backed by Industrifonden, NordicNinja VC and others. The company raised €3.9M ($4.3M) in Series A round on Nov 21, 2019. This brings Combinostics' total funding to €4.3M to date.



  • Year founded: 2014
  • Funding Info: €4.3M over 4 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Western Finland
  • State: Tampere
  • Country: Finland
Related businesses